Drug combo test halted early for business reasons
NCT ID NCT01995058
Summary
This study aimed to see if combining two drugs, cabozantinib and abiraterone, was safe and effective for men with advanced prostate cancer that had spread to their bones and was no longer responding to standard hormone therapy. Participants were assigned to receive different doses of the drug combination. The study was stopped early by the company running it for business reasons, so no results on whether the treatment worked were collected.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Scottsdale, Arizona, 85258, United States
-
Study site
Sedona, Arizona, 86336, United States
-
Study site
Tucson, Arizona, 85710, United States
-
Study site
Oxnard, California, 93030, United States
-
Study site
San Diego, California, 92108, United States
-
Study site
Aurora, Colorado, 80012, United States
-
Study site
Aurora, Colorado, 80045, United States
-
Study site
Athens, Georgia, 30607, United States
-
Study site
Atlanta, Georgia, 30318, United States
-
Study site
Peoria, Illinois, 61615, United States
-
Study site
Wichita, Kansas, 67214, United States
-
Study site
Las Vegas, Nevada, 89148, United States
-
Study site
Raleigh, North Carolina, 27607, United States
-
Study site
Tualatin, Oregon, 97062, United States
-
Study site
Charleston, South Carolina, 29414, United States
-
Study site
Greenville, South Carolina, 29605, United States
-
Study site
Myrtle Beach, South Carolina, 29572, United States
-
Study site
Dallas, Texas, 75246, United States
-
Study site
Houston, Texas, 77024, United States
-
Study site
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.